HealthEquity – Delivering Robust Numbers
I highlighted HealthEquity Inc. (NASDAQ:HQY) earlier this year as a great growth play in the ever-expanding Health Savings Accounts (HSAs) space. HealthEquity just reported big beats on both the top and bottom line, posting 28.8% year-over-year growth in revenue. HealthEquity’s IPO was in 2014, and since then the stock has returned 160% moving from ~$17 to currently ~$43 and touching $55 earlier this year. HealthEquity has been riding this secular growth market since its IPO and based on its recent string of earnings; the company is continuing this performance. Over the four quarters including the most recent earnings announcement, HealthEquity has beaten on both EPS and revenue while posting double-digit growth. HealthEquity posted annual revenue growth of 44% when comparing FY2016 to FY2017. The company has already posted robust revenue growth of 56% when comparing 1H2017 to 1H2018 (Figure 1). The sustainability of this growth will likely move in lock-step with the growth in the HSA market while optimizing revenues extracted from the investments within these accounts via offering investment advising, collecting fees from the investment line-up and its newly announced 401k with paired HSA offerings. I feel that HealthEquity will continue to post strong growth as it services the double-digit HSA growth market and manages more assets and investments within these accounts. As HealthEquity rolls out additional products such as the launch of its own 401k offerings paired with HSA accounts, revenue will continue to accelerate.
Figure 1 – Previous quarterly earnings for HealthEquity, posting double-digit growth
HealthEquity’s Q2 Earnings and Future Growth
HealthEquity reported another great quarter and the stock responded by appreciating by 12% after opening the next morning, jumping from $42 to $47. HealthEquity reported EPS of $0.21 and revenue of $56.9 million compared to last quarter with EPS of $0.23 and revenue of $55.4 million. These EPS and revenue figures beat estimates by $0.06 per share and $1.24 million with the latter revenue figure posting 28.8% year-over-year growth. Continue reading "HealthEquity Strikes Again"
Hello Traders everywhere. North Korean Minister of Foreign Affairs Ri Yong Ho said Thursday that the country may consider testing a hydrogen bomb in the Pacific Ocean. If Korea does indeed conduct the test, it would be North Korea's first nuclear test beyond its borders. That statement has left traders with an uneasy feeling heading into the weekend.
Apple Inc. (NASDAQ:AAPL) continues to be a drag on the DOW as it looks to close out the 3rd straight week of declines with a -5.5% loss on the week. This is by far their worst weekly performance ahead of a major product launch since the original iPhone was released back in 2007.
Crude oil can't make up its mind and is trading in a tight range right above the $50 mark for the week. This sidelines action comes after an OPEC gathering concluded with no decision on an extension or deepening of supply cuts.
Key levels to watch next week: Continue reading "Stock Market Slips On Threats From North Korea"
Analysis originally distributed on September 14, 2017 By: Michael Vodicka of Cannabis Stock Trades
Pets are big business in the US and around across the globe.
In 2016 U.S. consumers spent over $67 billion on pet-related products, up 11% from the year before.
While food accounts for the highest percent of spending, pet medications were close behind at $8 billion. Spending on pet medications is expected to grow another 10% in 2017 to $9 billion.
These huge sales numbers have gotten the attention of the cannabis industry. Capturing even a small percent of the pet medication market could mean hundreds of millions in profit.
That's why I am excited to share an early industry leader that most investors have never heard of.
- Sales are up more than 1,000% in the last 12 months.
- Shares have risen 122% since January.
With the cannabis for pets industry still in its early stages - I see plenty of room for growth for this undercover cannabis company. True Leaf Medicine International Ltd. (TRLFF) is a Canadian cannabis company founded in 2013 and headquartered in British Columbia.
Shares are listed on the Canadian Securities Exchange under the ticker symbol MJ. I see average daily trading volume around 100,000 shares here, so this stock has plenty of liquidity for most investors. Continue reading "Hemp For Pets Company Up 122% In 2017"
Back in December, I deduced that the Saudis had budgeted a little less than $53 for oil in 2017. Their budget was based on their belief that they didn't expect to see any U.S. shale oil production response in 2017. Saudi Energy Minister Khalid A. Al-Falih said it in answer to a question in the press conference after the OPEC/non-OPEC meeting (see video starting at 51:35). He backed-up his belief basing it on the time lag of when oil prices had peaked in 2014 and when production peaked in 2015.
After the deals went into effect on January 1st, oil prices remained above $50 per barrel. According to the EIA’s weekly production data, U.S. crude production rose by 318,000 b/d between the last week of December and the week ending March 3rd, just before Al-Fahil’s speech in Houston during on March 7th.
He said he is optimistic about the global oil market in the weeks and months ahead, but "I caution that my optimism should not tip investors into 'irrational exuberance' or wishful thinking that OPEC or the Kingdom will underwrite the investments of others at our own expense." Continue reading "What Oil Price Band Do The Saudis Want?"
Hello Traders everywhere. The Federal Reserve and Fed Chair Janet Yellen are stuck between a stronger global economy and a lull in U.S. inflation; the Fed is expected to announce whether it will raise interest rates for a third time this year or back off until prices rise to a level that they are comfortable with.
The Fed also is likely to announce a scheduled reduction of its approximately $4.2 trillion in holdings of bonds and mortgage-backed securities, most of it accumulated in response to the 2007-2009 financial crisis and recession.
Crude Oil is on the rise and trading above the $50 level today. The significant move today comes on the hell of news that gasoline stockpiles are at a new 22-month low and exports of crude and fuels surged.
Key levels to watch this week: Continue reading "Stocks Hesitate Ahead Of Fed Announcement"